vs
ICON PLC（ICLR）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
ICON PLC的季度营收约是瑞思迈的1.4倍（$2.0B vs $1.4B），瑞思迈净利率更高（27.6% vs 0.1%，领先27.5%），瑞思迈同比增速更快（11.0% vs 0.6%），ICON PLC自由现金流更多（$333.9M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs 0.6%）
ICON plc是总部位于爱尔兰的跨国医疗智能与临床研究服务机构，专注为全球医药健康领域客户提供专业研究及情报支持，截至2025年2月，已在全球55个国家布局业务，员工规模约4.19万人。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
ICLR vs RMD — 直观对比
营收规模更大
ICLR
是对方的1.4倍
$1.4B
营收增速更快
RMD
高出10.3%
0.6%
净利率更高
RMD
高出27.5%
0.1%
自由现金流更多
ICLR
多$22.7M
$311.2M
两年增速更快
RMD
近两年复合增速
0.6%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $1.4B |
| 净利润 | $2.4M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 4.2% | 34.6% |
| 净利率 | 0.1% | 27.6% |
| 营收同比 | 0.6% | 11.0% |
| 净利润同比 | -98.8% | 13.9% |
| 每股收益（稀释后） | $0.03 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICLRRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | $2.0B | $1.3B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $2.0B | $1.2B | ||
| Q2 24 | $2.1B | $1.2B | ||
| Q1 24 | $2.1B | $1.2B |
净利润ICLRRMD
| Q4 25 | — | $392.6M | ||
| Q3 25 | $2.4M | $348.5M | ||
| Q2 25 | $183.0M | $379.7M | ||
| Q1 25 | $154.2M | $365.0M | ||
| Q4 24 | — | $344.6M | ||
| Q3 24 | $197.1M | $311.4M | ||
| Q2 24 | $146.9M | $292.2M | ||
| Q1 24 | $187.4M | $300.5M |
毛利率ICLRRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率ICLRRMD
| Q4 25 | — | 34.6% | ||
| Q3 25 | 4.2% | 33.4% | ||
| Q2 25 | 10.4% | 33.7% | ||
| Q1 25 | 11.0% | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | 14.1% | 31.6% | ||
| Q2 24 | 10.8% | 31.2% | ||
| Q1 24 | 13.7% | 31.3% |
净利率ICLRRMD
| Q4 25 | — | 27.6% | ||
| Q3 25 | 0.1% | 26.1% | ||
| Q2 25 | 9.1% | 28.2% | ||
| Q1 25 | 7.7% | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | 9.7% | 25.4% | ||
| Q2 24 | 6.9% | 23.9% | ||
| Q1 24 | 9.0% | 25.1% |
每股收益（稀释后）ICLRRMD
| Q4 25 | — | $2.68 | ||
| Q3 25 | $0.03 | $2.37 | ||
| Q2 25 | $2.30 | $2.58 | ||
| Q1 25 | $1.90 | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | $2.36 | $2.11 | ||
| Q2 24 | $1.76 | $1.97 | ||
| Q1 24 | $2.25 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $468.9M | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $9.3B | $6.3B |
| 总资产 | $16.5B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资ICLRRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | $468.9M | $1.4B | ||
| Q2 25 | $390.4M | $1.2B | ||
| Q1 25 | $526.7M | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | $695.5M | $426.4M | ||
| Q2 24 | $506.6M | $238.4M | ||
| Q1 24 | $396.1M | $237.9M |
总债务ICLRRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益ICLRRMD
| Q4 25 | — | $6.3B | ||
| Q3 25 | $9.3B | $6.1B | ||
| Q2 25 | $9.6B | $6.0B | ||
| Q1 25 | $9.5B | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | $9.8B | $5.2B | ||
| Q2 24 | $9.6B | $4.9B | ||
| Q1 24 | $9.4B | $4.6B |
总资产ICLRRMD
| Q4 25 | — | $8.5B | ||
| Q3 25 | $16.5B | $8.3B | ||
| Q2 25 | $16.6B | $8.2B | ||
| Q1 25 | $16.7B | $7.6B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | $17.2B | $7.2B | ||
| Q2 24 | $17.0B | $6.9B | ||
| Q1 24 | $17.0B | $6.8B |
负债/权益比ICLRRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $387.6M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $333.9M | $311.2M |
| 自由现金流率自由现金流/营收 | 16.3% | 21.9% |
| 资本支出强度资本支出/营收 | 2.6% | 2.0% |
| 现金转化率经营现金流/净利润 | 164.59× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $1.0B | $1.8B |
8季度趋势，按日历期对齐
经营现金流ICLRRMD
| Q4 25 | — | $339.7M | ||
| Q3 25 | $387.6M | $457.3M | ||
| Q2 25 | $146.2M | $538.8M | ||
| Q1 25 | $268.2M | $578.7M | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | $402.7M | $325.5M | ||
| Q2 24 | $218.6M | $440.1M | ||
| Q1 24 | $327.1M | $402.0M |
自由现金流ICLRRMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | $333.9M | $414.4M | ||
| Q2 25 | $113.9M | $508.2M | ||
| Q1 25 | $239.3M | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | $359.3M | $307.7M | ||
| Q2 24 | $182.3M | $415.2M | ||
| Q1 24 | $299.9M | $380.8M |
自由现金流率ICLRRMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | 16.3% | 31.0% | ||
| Q2 25 | 5.6% | 37.7% | ||
| Q1 25 | 12.0% | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | 17.7% | 25.1% | ||
| Q2 24 | 8.6% | 33.9% | ||
| Q1 24 | 14.3% | 31.8% |
资本支出强度ICLRRMD
| Q4 25 | — | 2.0% | ||
| Q3 25 | 2.6% | 3.2% | ||
| Q2 25 | 1.6% | 2.3% | ||
| Q1 25 | 1.4% | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 2.1% | 1.5% | ||
| Q2 24 | 1.7% | 2.0% | ||
| Q1 24 | 1.3% | 1.8% |
现金转化率ICLRRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | 164.59× | 1.31× | ||
| Q2 25 | 0.80× | 1.42× | ||
| Q1 25 | 1.74× | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 2.04× | 1.05× | ||
| Q2 24 | 1.49× | 1.51× | ||
| Q1 24 | 1.74× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICLR
| Other Customers | $681.3M | 33% |
| Clients1125 | $549.4M | 27% |
| Clients15 | $503.3M | 25% |
| Clients610 | $308.8M | 15% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
